NEUP Insider Trading Activity and SEC Form 4 Filings
NEUP insider trading summary
No open-market insider purchases or sales of Neuphoria Therapeutics Inc. (NEUP) have been reported on SEC Form 4 in the past 12 months.
Latest NEUP insider buys and sells
| Date | Insider | Role | Type | Value |
|---|---|---|---|---|
| Oct 21, 2025 | Lynx1 Capital Management LP | 10% Owner | Buy | $3.3M (639,110 @ $5.14) |
| Oct 21, 2025 | Weston Nichols | 10% Owner | Buy | $3.3M (639,110 @ $5.14) |
Source: SEC Form 4 filings. Open-market purchases (code P) and sales (code S) only; option exercises, grants and gifts are excluded.